Euroscreen Fast Logo
Navigate to...
  • Testing Catalogue
  • Assay Development
    • Cell Line Development
    • Specialized assays
  • Target Discovery
  • Profiling
    • 57 GPCR Diversity panel
    • Orphan GPCR panel
    • Therapeutic area panels
    • Receptor family panels
    • Safety panel
Get a quote
  • About us
  • Privacy Policy
  • Cookie Policy
  • Contact Us
Get a quote
What's up ?

Latest news

News listing

Image for EuroscreenFast is sponsoring the 12th Pharmacology of GPCRs & MPGPCR event in Melbourne
01 / 07 / 2026

EuroscreenFast is sponsoring the 12th Pharmacology of GPCRs & MPGPCR event in Melbourne

Image for EuroscreenFast is at Discovery on Target 2024 in Boston
08 / 06 / 2026

EuroscreenFast is at Discovery on Target 2024 in Boston

Image for Meet EuroscreenFast at Discovery & Development Europe 2026
01 / 06 / 2026

Meet EuroscreenFast at Discovery & Development Europe 2026

Image for EuroscreenFast is at Discovery on Target 2024 in Boston
10 / 09 / 2024

EuroscreenFast is at Discovery on Target 2024 in Boston

Image for EuroscreenFast Announces Strategic Partnership with Indian Solutions Provider BioPharma Consultants
30 / 07 / 2024

EuroscreenFast Announces Strategic Partnership with Indian Solutions Provider BioPharma Consultants

Image for EuroscreenFast is at Bio Integrates 2024 - Cambridge, UK.
08 / 05 / 2024

EuroscreenFast is at Bio Integrates 2024 - Cambridge, UK.

Image for EuroscreenFast at Discovery Europe 2024 in Basel
24 / 04 / 2024

EuroscreenFast at Discovery Europe 2024 in Basel

Image for EuroscreenFast is attending Swiss Biotech Day 2024
03 / 03 / 2024

EuroscreenFast is attending Swiss Biotech Day 2024

Image for EuroscreenFast at GPCR Summit in Boston
14 / 02 / 2024

EuroscreenFast at GPCR Summit in Boston

Image for EuroscreenFast maintains its activities despite Covid-19
18 / 03 / 2020

EuroscreenFast maintains its activities despite Covid-19

EuroscreenFast maintains activities despite Covid-19

serotonin 5-HT1F cAMP agonist
19 / 08 / 2019

New Publication in British Journal of Pharmacology

EuroscreenFast work published in British Journal of Pharmacology

31 / 12 / 2018

EuroscreenFast activities transferred to EPICS Therapeutics SA

EPICS Therapeutics SA acquires Ogeda former assets, including the EuroscreenFast Business Unit which will continue to provide the same high-quality GPCR screening and assay development services

  • 1
  • 2
Next Last
Euroscreen Fast Logo
  • About us
  • Privacy Policy
  • Cookie Policy
  • Contact Us
  • Copyright © 2019 Epics Therapeutics S.A.
  • Facebook
  • Linked In
  • Twitter
European FEDER

This website uses cookies useful for your browsing. By using this site, you agree to the use of these cookies. More information on how we use cookies can be found in our Cookie Policy.